CSG-002

N/A

Report date: 2025/01/15 20:00:32

Base Information

Drug NameCSG-002

Drug Alias NameCSG-002

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesCarsgen Therapeutics ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCarsgen Therapeutics ltd

Active IndicationsN/A

Inactive IndicationsStomach Neoplasms

Other Information

ATC CodeN/A